Guizhou Xinbang Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Xinbang Pharmaceutical Company Limited with three other
companies in this sector in China:
Tong Ren Tang Technologies Company Limited
sales of 3.99 billion Chinese Renmimbi [US$579.17 million]
of which 73%
was The Company),
Northeast Pharmaceutical Group Co., Ltd.
(3.83 billion Chinese Renmimbi [US$556.34 million]
of which 62%
was Pharmaceutical Products), and
Zhejiang Medicine Co., Ltd.
(4.50 billion Chinese Renmimbi [US$652.99 million]
of which 41%
During the year ended December of 2015, sales at
Guizhou Xinbang Pharmaceutical Company Limited were 4.18 billion Chinese Renmimbi (US$606.72 million).
increase of 68.7%
versus 2014, when the company's sales were 2.48 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Guizhou Xinbang Pharmaceutical Company Limited
(and since 2010, sales have increased a total of 1,211%).
Sales of Medical Services saw an increase
136.3% in 2015, from
443.72 million Chinese Renmimbi to 1.05 billion Chinese Renmimbi.
Not all segments of Guizhou Xinbang Pharmaceutical Company Limited experienced an increase in sales in 2015:
sales of Corp Farming fell 5.3% to 5.39 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).